Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 56

1.

Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.

Jääskeläinen P, Vangipurapu J, Raivo J, Kuulasmaa T, Heliö T, Aalto-Setälä K, Kaartinen M, Ilveskoski E, Vanninen S, Hämäläinen L, Melin J, Kokkonen J, Nieminen MS; FinHCM Study Group, Laakso M, Kuusisto J.

ESC Heart Fail. 2019 Apr;6(2):436-445. doi: 10.1002/ehf2.12420. Epub 2019 Feb 18.

2.

Permanent work disability in patients ≤50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study).

Lautamäki A, Gunn JM, Airaksinen KEJ, Biancari F, Kajander OA, Anttila V, Heikkinen J, Eskola M, Ilveskoski E, Mennander A, Korpilahti K, Wistbacka JO, Kiviniemi TO.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):101-106. doi: 10.1093/ehjqcco/qcw043.

PMID:
28927176
3.

[Percutaneous treatment of coronary chronic total occlusions].

Kajander OA, Ilveskoski E, Jussila R.

Duodecim. 2016;132(7):618-26. Review. Finnish.

PMID:
27188085
4.

Ultrasound Screening of Men with Coronary Artery Disease for Abdominal Aortic Aneurysms: A Prospective Dual Center Study.

Vänni V, Hakala T, Mustonen J, Turtiainen J, Rissanen TT, Kajander O, Ilveskoski E, Koivumäki J, Eskola M, Hernesniemi J.

Scand J Surg. 2016 Dec;105(4):235-240. doi: 10.1177/1457496915626839. Epub 2016 Jun 22.

PMID:
26929281
5.

[Update on Current Care Guidelines. Current Care Guideline: Stable Coronary Artery Disease].

Porela P, Mäntylä P, Blek-Vehkaluoto M, Ilveskoski E, Juvonen T, Kujanpää T, Loimaala A, Meinander T, Mäenpää E, Romppanen H, Saraste A, Tierala JI; Tiivistelmä.

Duodecim. 2015;131(10):967-8. Finnish.

PMID:
26237876
6.

Predictors of permanent work disability among ≤50-year-old patients undergoing percutaneous coronary intervention.

Gunn J, Kiviniemi T, Biancari F, Kajander O, Mäkikallio T, Eskola M, Ilveskoski E, Korpilahti K, Wistbacka JO, Anttila V, Heikkinen J, Airaksinen J.

Scand J Work Environ Health. 2015 Sep 1;41(5):460-6. doi: 10.5271/sjweh.3508. Epub 2015 Jun 17.

7.

Prognosis and disease progression in patients under 50 years old undergoing PCI: the CRAGS (Coronary aRtery diseAse in younG adultS) study.

Lautamäki A, Airaksinen KE, Kiviniemi T, Vinco G, Ribichini F, Gunn J, Anttila V, Heikkinen J, Korpilahti K, Karjalainen P, Kajander O, Eskola M, Ilveskoski E, Axelsson T, Gudbjartsson T, Jeppsson A, Biancari F.

Atherosclerosis. 2014 Aug;235(2):483-7. doi: 10.1016/j.atherosclerosis.2014.05.953. Epub 2014 Jun 9.

PMID:
24953487
8.

A new common mutation in the cardiac beta-myosin heavy chain gene in Finnish patients with hypertrophic cardiomyopathy.

Jääskeläinen P, Heliö T, Aalto-Setälä K, Kaartinen M, Ilveskoski E, Hämäläinen L, Melin J, Kärkkäinen S, Peuhkurinen K, Nieminen MS, Laakso M; FinHCM Study Group, Kuusisto J.

Ann Med. 2014 Sep;46(6):424-9. doi: 10.3109/07853890.2014.912834. Epub 2014 Jun 3.

PMID:
24888384
9.

Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).

Biancari F, Gudbjartsson T, Heikkinen J, Anttila V, Mäkikallio T, Jeppsson A, Thimour-Bergström L, Mignosa C, Rubino AS, Kuttila K, Gunn J, Wistbacka JO, Teittinen K, Korpilahti K, Onorati F, Faggian G, Vinco G, Vassanelli C, Ribichini F, Juvonen T, Axelsson TA, Sigurdsson AF, Karjalainen PP, Mennander A, Kajander O, Eskola M, Ilveskoski E, D'Oria V, De Feo M, Kiviniemi T, Airaksinen KE.

Am J Cardiol. 2014 Jul 15;114(2):198-205. doi: 10.1016/j.amjcard.2014.04.025. Epub 2014 May 2.

PMID:
24878127
10.

Association of resting heart rate with cardiovascular function: a cross-sectional study in 522 Finnish subjects.

Koskela JK, Tahvanainen A, Haring A, Tikkakoski AJ, Ilveskoski E, Viitala J, Leskinen MH, Lehtimäki T, Kähönen MA, Kööbi T, Niemelä O, Mustonen JT, Pörsti IH.

BMC Cardiovasc Disord. 2013 Nov 15;13:102. doi: 10.1186/1471-2261-13-102.

11.

Age-dependent interaction of apolipoprotein E gene with eastern birthplace in Finland affects severity of coronary atherosclerosis and risk of fatal myocardial infarction--Helsinki Sudden Death Study.

Tyynelä P, Goebeler S, Ilveskoski E, Mikkelsson J, Perola M, Lehtimäki T, Karhunen PJ.

Ann Med. 2013 May;45(3):213-9. doi: 10.3109/07853890.2012.727021. Epub 2012 Oct 30.

PMID:
23110590
12.

Two founder mutations in the alpha-tropomyosin and the cardiac myosin-binding protein C genes are common causes of hypertrophic cardiomyopathy in the Finnish population.

Jääskeläinen P, Heliö T, Aalto-Setälä K, Kaartinen M, Ilveskoski E, Hämäläinen L, Melin J, Nieminen MS, Laakso M, Kuusisto J; FinHCM study group, Kervinen H, Mustonen J, Juvonen J, Niemi M, Uusimaa P, Huttunen M, Kotila M, Pietilä M.

Ann Med. 2013 Feb;45(1):85-90. doi: 10.3109/07853890.2012.671534. Epub 2012 Apr 2.

PMID:
22462493
13.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators.

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.

14.

Reduced systemic vascular resistance in healthy volunteers with presyncopal symptoms during a nitrate-stimulated tilt-table test.

Tahvanainen A, Koskela J, Leskinen M, Ilveskoski E, Nordhausen K, Kähönen M, Kööbi T, Mustonen J, Pörsti I.

Br J Clin Pharmacol. 2011 Jan;71(1):41-51. doi: 10.1111/j.1365-2125.2010.03794.x.

15.

Severe hypocalcemia simulating ST-elevation myocardial infarction.

Ilveskoski E, Sclarovsky S, Nikus K.

Am J Emerg Med. 2012 Jan;30(1):256.e3-6. doi: 10.1016/j.ajem.2010.10.021. Epub 2010 Dec 3.

PMID:
21129889
16.

Birthplace in area with high coronary heart disease mortality predicts the severity of coronary atherosclerosis among middle-aged Finnish men who had migrated to capital area: the Helsinki sudden death study.

Tyynelä P, Goebeler S, Ilveskoski E, Mikkelsson J, Perola M, Löytönen M, Karhunen PJ.

Ann Med. 2010 May 6;42(4):286-95. doi: 10.3109/07853891003621471.

PMID:
20350252
17.

Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.

Viiri LE, Viiri KM, Ilveskoski E, Huhtala H, Mäki M, Tienari PJ, Perola M, Lehtimäki T, Karhunen PJ.

Circ Cardiovasc Genet. 2008 Dec;1(2):107-16. doi: 10.1161/CIRCGENETICS.108.791764. Epub 2008 Oct 15.

PMID:
20031552
18.

Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study.

Hernesniemi JA, Karhunen PJ, Oksala N, Kähönen M, Levula M, Rontu R, Ilveskoski E, Kajander O, Goebeler S, Viiri LE, Hurme M, Lehtimäki T.

Eur Heart J. 2009 Dec;30(23):2939-46. doi: 10.1093/eurheartj/ehp316. Epub 2009 Aug 17.

PMID:
19687159
19.

Non-invasive measurement of the haemodynamic effects of inhaled salbutamol, intravenous L-arginine and sublingual nitroglycerin.

Tahvanainen A, Leskinen M, Koskela J, Ilveskoski E, Alanko J, Kähönen M, Kööbi T, Lehtimäki L, Moilanen E, Mustonen J, Pörsti I.

Br J Clin Pharmacol. 2009 Jul;68(1):23-33. doi: 10.1111/j.1365-2125.2009.03434.x.

20.

Ageing and cardiovascular responses to head-up tilt in healthy subjects.

Tahvanainen A, Leskinen M, Koskela J, Ilveskoski E, Nordhausen K, Oja H, Kähönen M, Kööbi T, Mustonen J, Pörsti I.

Atherosclerosis. 2009 Dec;207(2):445-51. doi: 10.1016/j.atherosclerosis.2009.06.001. Epub 2009 Jun 11.

PMID:
19580971

Supplemental Content

Loading ...
Support Center